Emergency Use Authorizations (eua) - Infectious Diseases

Relevant Publications

Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19.

Issue Release: 2024

Health Equity and Access to COVID-19 Treatments Available through Emergency Use Authorizations.

Issue Release: 2024

The evidence base for emergency use authorizations for COVID-19 treatments: A rapid review.

Issue Release: 2023

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.

Issue Release: 2023

The problem is obtaining knowledge: a qualitative analysis of provider barriers and accelerators to rapid adoption of new treatment in a public health emergency.

Issue Release: 2023

Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations.

Issue Release: 2023

Standardization and Comparison of Emergency Use Authorized COVID-19 Assays and Testing Laboratories.

Issue Release: 2023

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.

Issue Release: 2022

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds.

Issue Release: 2022

A precise review on NAATs-based diagnostic assays for COVID-19: A motion in fast POC molecular tests.

Issue Release: 2022

Immunomodulatory therapies for COVID-19.

Issue Release: 2022

RxLegal: Emergency Use Authorizations.

Issue Release: 2022

Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents.

Issue Release: 2021

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.

Issue Release: 2021

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.

Issue Release: 2021

The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.

Issue Release: 2021

SARS-CoV-2 serology testing: Progress and challenges.

Issue Release: 2021

BNT162b2 mRNA COVID-19 Vaccine: First Approval.

Issue Release: 2021

EUAdb: a resource for COVID-19 test development.

Issue Release: 2020

Public acceptance of peramivir during the 2009 H1N1 influenza pandemic: implications for other drugs or vaccines under emergency use authorizations.

Issue Release: 2015

Why Are Regular Health Check-Ups Important?

What Are the Ethical Considerations?

What is Prevalence?

How to Combat Antimicrobial Resistance?

How Do Serological Tests Work?

How is Protein Targeting Relevant to Infectious Diseases?

What Causes ARDS in Infectious Diseases?

What Types of Assays are Used in HTS for Infectious Diseases?

What is the Prognosis for Cervical Cancer?

How Can Gonorrhea be Prevented?

Partnered Content Networks

Relevant Topics